Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
antonio.chistolini@uniroma1.it
Antonio Chistolini
Ricercatore
Struttura:
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
E-mail:
antonio.chistolini@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillations: the MAS study
BLOOD ADVANCES
2024
Evaluation of VTE-PREDICT Risk Score in Patients Receiving Low-Dose DOACs for Venous Thromboembolism (VTE) Secondary Prophylaxis
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
2024
Secondary Prophylaxis of Venous Thromboembolism (VTE) with Low Dose Apixaban or Rivaroxaban: Results from a Patient Population with More than 2 Years of Median Follow-up
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
2024
More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study
BLOOD ADVANCES
2024
Increased von Willebrand Factor Platelet-Binding Capacity Is Related to Poor Prognosis in COVID-19 Patients
THROMBOSIS AND HAEMOSTASIS
2023
Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS
2023
Vaccine-induced immune thrombotic thrombocytopenia: a possible pathogenetic role of ChAdOx1 nCoV-19 vaccine encoded soluble SARS-CoV-2 spike protein
HAEMATOLOGICA
2022
Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants: comparison between patients with major congenital thrombophilia versus non-thrombophilic patients
INTERNAL AND EMERGENCY MEDICINE
2022
Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register
INTERNAL AND EMERGENCY MEDICINE
2022
Thromboembolic events following mRNA vaccines for COVID 19: a case series
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
2022
Immune thrombocytopenia during covid-19 pandemic: An italian monocentric experience
EJHAEM
2022
Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry
213S2 (2022) S11–S42
2022
Diagnostica di laboratorio e strumentale
Ematologia Smart, Edizioni Idelson Gnocchi 1908
2022
Complicanze in corso di emopatie ed emergenze emorragiche e trombotiche
Ematologia Smart, Edizioni Idelson Gnocchi 1908
2022
Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study
BIOMOLECULES
2022
SARS-CoV-2 infection predicts larger infarct volume in patients with acute ischemic stroke
FRONTIERS IN CARDIOVASCULAR MEDICINE
2022
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
2022
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients-30 months follow-up": Comment from Serrao et al
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
2022
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox?
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
2021
Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going?
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
2021
1
2
3
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma